Natural killer cells act as the immune system’s rapid-response team, but the stress of anxiety and insomnia may be quietly thinning their ranks. A study of young women in Saudi Arabia found that both ...

The latest deal, announced Monday, reportedly values the combined SpaceX-xAI at $1.25 trillion ahead of a potential mega IPO later this year. Musk in a SpaceX blog post said the deal would "accelerate ...

First it was rockets. Then AI. Now Elon Musk is combining both into one massive company. SpaceX acquired xAI on Monday, creating the most valuable private company in the world at a combined valuation ...

Warning: This graphic requires JavaScript. Please enable JavaScript for the best experience. You know how hard it is to be the most distinct person at the Luxor Hotel ...

Microsoft has woven its generative AI technology throughout Microsoft 365, the company’s productivity suite. Its Copilot AI assistant is most often used in M365 apps for text-oriented actions, such as ...

Let’s say it’s 2036, and scientists are working on a new class of drugs. These medications are mirror-image versions of the molecules your body uses to fight disease. Their big advantage is that ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...

Georgetown University's Lombardi Comprehensive Cancer Center researchers have identified a new way to reprogram T cells, which are infection and tumor-fighting white blood cells, so that they have a ...

It may be a surprise to learn that you can define names of cells in Microsoft Excel instead of using the letter and number combinations. This makes it friendlier to read and understand. For example, ...

The items were taken in the late 19th century from what was then called the Dutch East Indies. Indonesia had been trying to get them back for decades. By Nina Siegal Reporting from Amsterdam The ...

Epic Games launched its mobile store for iPhone and iPad in the EU last year, and it has since established a popular program of weekly game giveaways. This week, it is making one of the most awarded ...

CD7 is an attractive target for chimeric antigen receptor (CAR) T-cell therapy in relapsed or refractory T-cell acute lymphoblastic leukemia (ALL). Supportive results of first-in-human studies of base ...